Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.36 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7435031 | 0.98 | MAPT (0.39) | MAPTGAAHSPA1APTPN7TDP1 | |
| SCHEMBL1286805 | 0.84 | MAPT (0.38) | MAPTGAAALDH1A1MEN1KMT2A | |
| SCHEMBL27348437 | 0.84 | MAPT (0.38) | MAPTGAAALDH1A1MEN1KMT2A | |
| SCHEMBL31301236 | 0.84 | MAPT (0.38) | MAPTGAAALDH1A1MEN1KMT2A | |
| 2-Pyrrolidone SCHEMBL27602198 | 0.83 | OR51E2 (0.39) | MAPTGAAHSPA1APTPN7TDP1 | |
| Hydrochloric Acid SCHEMBL27965612 | 0.82 | MAPT (0.36) | MAPTGAAALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL3250625 | 0.80 | MAPT (0.40) | MAPTGAAALDH1A1MEN1KMT2A | |
| SCHEMBL14603902 | 0.80 | P2RX4 (0.37) | MAPTGAAMEN1KMT2ARAB9A | |
| SCHEMBL8700492 | 0.78 | CYP1A2 (0.42) | GAAALDH1A1MEN1KMT2ARAB9A | |
| SCHEMBL28219643 | 0.77 | FABP7 (0.43) | TDP1ALDH1A1KMT2AMAPK1P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105051013-A | Laquinimod sodium crystals and improved process for their manufacture | TEVA PHARMA | 2015-11-11 | — | — | CN | claimed |
| CN-102964301-A | Method for synthesizing IOX2 | CGENE TECH SUZHOU CHINA CO LTD | 2013-03-13 | — | — | CN | claimed |
| EP-2323978-A1 | AMIDE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2011-05-25 | — | — | EP | claimed |
| WO-2010018874-A1 | AMIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-02-18 | — | — | WO | claimed |
| CN-101431998-A | Containing CBxPharmaceutical compositions of cannabinoid receptor modulators and potassium channel modulators | SOLVAY PHARM GMBH (DE) | 2009-05-13 | — | — | CN | claimed |
| EP-1807422-A1 | 5-HT4 RECEPTOR AGONIST COMPOUNDS | Theravance, Inc. (US) | 2007-07-18 | — | — | EP | claimed |
| WO-2006052640-A1 | 5-HT4 RECEPTOR AGONIST COMPOUNDS | THERAVANCE, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| EP-1534703-A2 | ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR | ABBOTT LABORATORIES (US) | 2005-06-01 | — | — | EP | claimed |
| EP-1478645-A2 | QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS | Amgen Inc. (US) | 2004-11-24 | — | — | EP | claimed |
| WO-2003106452-A2 | ANTAGONISTS OF MELANIN CONCENTRATING HORMONE RECEPTOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2003-12-24 | — | — | WO | claimed |
| WO-2003066630-A2 | QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS | AMGEN INC. (US) | 2003-08-14 | — | — | WO | claimed |
| CN-1337950-A | 2-oxoquinoline compounds and medicinal uses thereof | JAPAN TOBACCO INC (JP) | 2002-02-27 | — | — | CN | claimed |
| EP-0885232-A1 | NOVEL 1(2H) QUINOLINE CARBOXYLIC ACID DERIVATIVES, METHOD FOR PREPARING SAME, AND USE THEREOF FOR SYNTHESISING SUBSTANCES HAVING ANTIBIOTIC PROPERTIES | HOECHST MARION ROUSSEL (FR) | 1998-12-23 | — | — | EP | claimed |
| WO-1997031926-A1 | NOVEL 1(2H) QUINOLINE CARBOXYLIC ACID DERIVATIVES, METHOD FOR PREPARING SAME, AND USE THEREOF FOR SYNTHESISING SUBSTANCES HAVING ANTIBIOTIC PROPERTIES | HOECHST MARION ROUSSEL (FR) | 1997-09-04 | — | — | WO | claimed |
| WO-2023165373-A1 | MICROMOLECULAR PCSK9 PROTEIN DEGRADATION AGENT, PREPARATION METHOD THEREFOR, AND USE THEREOF | 复旦大学 | 2023-09-07 | — | — | WO | disclosed |
| EP-4232444-A1 | HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4126844-A1 | AMIDE COMPOUNDS AND USES THEREOF | Hutchison Medipharma Limited (CN) | 2023-02-08 | — | — | EP | disclosed |
| EP-0303387-A1 | Kynurenic acid derivatives useful in the treatment of neurodegenerative disorders | MERCK SHARP & DOHME LTD. (GB) | 1989-02-15 | — | — | EP | disclosed |
| CN-1030237-A | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1989-01-11 | — | — | CN | disclosed |
| EP-0287951-A2 | 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |